Page 185 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P0376 STRATIFICATION OF HEPATOCELLULAR CARCINOMA. ePOSTERS
P0377 THE PROGNOSTIC SCORE NIACE, AN ADDITIONAL AID TO
P0378 THE BARCELONA CLINIC LIVER CANCER (BCLC) STAGING
P0379 SYSTEM? MULTICENTER STUDY
P0380 Xavier Adhoute, Guillaume Penaranda, Jean-Frédéric Blanc,
Julien Edeline, Sebastien Naude, Hervé Perrier, Olivier Monnet,
Paul Castellani, Valerie Oules, Olivier Bayle, Guilaume Conroy,
Souad Benali, Gaelle Lefolgoc, Bernard Pol, Jean-Pierre Bronowicki,
Jean-Luc Raoul, Marc Bourliere*, France

TUMOR NUMBER IMPROVES THE PROGNOSTIC VALUE
OF HEPATOMA ARTERIAL-EMBOLIZATION SCORE
IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
TREATED WITH CHEMOEMBOLIZATION
Yehyun Park, Seung Up Kim*, Beom Kyung Kim, Jun Yong Park,
Do Young Kim, Sang Hoon Ahn,Yong Eun Park, Ji Hye Park,Yong Il Lee,
Hye Ryong Yun, Kwang-Hyub Han, South Korea

TIME TO PROGRESSION OF AFP IS AN INDEPENDENT
PROGNOSTIC FACTOR OF SURVIVAL IN HEPATOCELLULAR
CARCINOMA TREATED WITH SORAFENIB. INTERNAL
VALIDATION
Maria Varela*, Lorena Blanco-García, Olegario Castaño-Fernández,
Maria Luisa González-Diéguez, Valle Cadahía-Rodrigo, Carmen Álvarez-
Navascués, Ramón Pérez-Álvarez, Alicia Mesa, Luis Hernández-
Luyando, Manuel Rodríguez, Spain

CANCER RELATED SYMPTOMS (PERFORMANCE STATUS
0 VS 1) DETERMINE PROGNOSIS OF HEPATOCELLULAR
CARCINOMA PATIENTS TREATED WITH SORAFENIB.
ANALYSIS OF A PROSPECTIVE DATA COLLECTION IN 207
PATIENTS
María Varela *, Maria Reig, Carmen Álvarez Navascués,
Alejandro Forner, Valle Cadahía, Álvaro DíazMaria Luisa González-
Diéguez, Neus Llarch, Manuel Rodríguez, Jordi Bruix, Spain

NEW RECOGNIZATION OF THE NATURAL HISTORY
AND GROWTH PATTERN OF HEPATIC HEMANGIOMA IN
ADULTS
Jing Li,Yiqun Yan*, Liang Huang, Caifeng Liu, Jianjun Yan, Feng Xu,
China

Vienna, Austria • April 22–26, 2015 185